Students and lifelong learners are invited to explore a new interest, enhance their resume or strengthen their professional skills through Cornell’s Fall Part-Time Study Program, which runs Aug. 22 – Dec. 17, 2022. Registration for most students begins August 1.
A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.
A smart sensor that attaches to the tip of a syringe can measure, in real time, the concentration and viability of the cells that pass through it – a potential breakthrough for biomedical 3D printing and cell therapy.
Due to faster decomposition, disposable and plasticized biodegradable medical gowns introduce greenhouse gas discharge problems in landfills, according to new Cornell engineering research.
The hackathons, run by Entrepreneurship at Cornell, are open to undergraduate and graduate students from any field and major and take place from Friday evenings through Sunday afternoon.
For her work in developing and teaching nutrition and food justice curricula to adolescents in New York City, Hannah Rudt ’23 has won the 2023 National Student Employee of the Year award – the first Cornellian to ever receive this honor.
A team of faculty members and researchers, led by Gen Meredith from the College of Veterinary Medicine’s Department of Public and Ecosystem Health, has partnered with eCornell to launch the Public Health Essentials online certificate program.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.
Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.
A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.